drugset / Trial / NCT06645522
Safety and Efficacy of Edaravone Dexborneol for Acute Ischemic Stroke
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the efficacy and safety of edaravone dexborneol in treating acute ischemic stroke.
Timeline
- Start
- 2024-10-30
- Primary completion
- 2026-10-30
- Completion
- 2027-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Edaravone Dexborneol | Unknown | 36 mg | Other |